Psomagen, Inc. (KOSDAQ:950200)
South Korea
· Delayed Price · Currency is KRW 3,965.00
+35.00 (0.89%)
Last updated: Jun 9, 2025
Psomagen Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 45,622 | 43,664 | 32,275 | 43,374 |
| Revenue Growth (YoY) | 37.46% | 35.29% | -25.59% | - |
| Cost of Revenue | 35,564 | 34,094 | 24,811 | 31,301 |
| Gross Profit | 10,058 | 9,570 | 7,464 | 12,074 |
| Selling, General & Admin | 12,529 | 12,326 | 8,845 | 10,105 |
| Research & Development | 1,091 | 1,091 | 1,353 | 1,943 |
| Other Operating Expenses | 607.97 | 607.97 | 436.41 | 467.49 |
| Operating Expenses | 15,003 | 14,800 | 11,016 | 13,548 |
| Operating Income | -4,945 | -5,230 | -3,553 | -1,475 |
| Interest Expense | -504.07 | -504.07 | -219.19 | -242.02 |
| Interest & Investment Income | 397.05 | 397.05 | 387.53 | 97.39 |
| Earnings From Equity Investments | -114.75 | -195.2 | 14.18 | 247.24 |
| Currency Exchange Gain (Loss) | -6.07 | -6.07 | -8.42 | 1.58 |
| Other Non Operating Income (Expenses) | -400.64 | 71.16 | -43.28 | 0.64 |
| EBT Excluding Unusual Items | -5,574 | -5,467 | -3,422 | -1,370 |
| Gain (Loss) on Sale of Investments | - | - | - | 732.21 |
| Gain (Loss) on Sale of Assets | 252.29 | 252.29 | -188.94 | 98.2 |
| Asset Writedown | -1,008 | -1,008 | -772.92 | -502.89 |
| Pretax Income | -6,330 | -6,223 | -4,384 | -1,042 |
| Income Tax Expense | 8.74 | 8.71 | 10.06 | 5.96 |
| Earnings From Continuing Operations | -6,339 | -6,232 | -4,394 | -1,048 |
| Minority Interest in Earnings | 692.49 | 613.95 | 105.38 | - |
| Net Income | -5,646 | -5,618 | -4,288 | -1,048 |
| Net Income to Common | -5,646 | -5,618 | -4,288 | -1,048 |
| Shares Outstanding (Basic) | 20 | 19 | 19 | 19 |
| Shares Outstanding (Diluted) | 20 | 19 | 19 | 19 |
| Shares Change (YoY) | 3.32% | 0.10% | 0.31% | - |
| EPS (Basic) | -287.53 | -292.05 | -223.15 | -54.72 |
| EPS (Diluted) | -287.53 | -292.05 | -223.15 | -54.72 |
| Free Cash Flow | 1,180 | -1,001 | -3,215 | -3,024 |
| Free Cash Flow Per Share | 60.07 | -52.06 | -167.28 | -157.84 |
| Gross Margin | 22.05% | 21.92% | 23.13% | 27.84% |
| Operating Margin | -10.84% | -11.98% | -11.01% | -3.40% |
| Profit Margin | -12.38% | -12.87% | -13.29% | -2.42% |
| Free Cash Flow Margin | 2.59% | -2.29% | -9.96% | -6.97% |
| EBITDA | 400 | -96.26 | 421.96 | 2,372 |
| EBITDA Margin | 0.88% | -0.22% | 1.31% | 5.47% |
| D&A For EBITDA | 5,345 | 5,134 | 3,975 | 3,847 |
| EBIT | -4,945 | -5,230 | -3,553 | -1,475 |
| EBIT Margin | -10.84% | -11.98% | -11.01% | -3.40% |
| Advertising Expenses | - | 1,250 | 273.88 | 942.34 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.